[go: nahoru, domu]

WO2003093795A3 - Device and method for analytical cell imaging - Google Patents

Device and method for analytical cell imaging Download PDF

Info

Publication number
WO2003093795A3
WO2003093795A3 PCT/US2003/013842 US0313842W WO03093795A3 WO 2003093795 A3 WO2003093795 A3 WO 2003093795A3 US 0313842 W US0313842 W US 0313842W WO 03093795 A3 WO03093795 A3 WO 03093795A3
Authority
WO
WIPO (PCT)
Prior art keywords
cells
immunomagnetically
chamber
enriched
tumor
Prior art date
Application number
PCT/US2003/013842
Other languages
French (fr)
Other versions
WO2003093795A2 (en
Inventor
Michael Trainer
Original Assignee
Immunivest Corp
Michael Trainer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunivest Corp, Michael Trainer filed Critical Immunivest Corp
Priority to CA002484730A priority Critical patent/CA2484730A1/en
Priority to JP2004501911A priority patent/JP2005524833A/en
Priority to EP03728685A priority patent/EP1501917A4/en
Priority to AU2003234459A priority patent/AU2003234459A1/en
Publication of WO2003093795A2 publication Critical patent/WO2003093795A2/en
Publication of WO2003093795A3 publication Critical patent/WO2003093795A3/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10—Investigating individual particles
    • G01N15/14—Optical investigation techniques, e.g. flow cytometry
    • G01N15/1429—Signal processing
    • G01N15/1433—Signal processing using image recognition
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/645—Specially adapted constructive features of fluorimeters
    • G01N21/6456—Spatial resolved fluorescence measurements; Imaging
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326—Magnetic particles
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57492—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Optics & Photonics (AREA)
  • Dispersion Chemistry (AREA)
  • Signal Processing (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

In patients having carcinomas tumor cells shed into the blood, enumeration and characterization of these cells offers the opportunity to obtain a 'real time' biopsy of the tumor and may improve the management of the disease. The frequency of circulating tumor cells is rare (<1cell/ml) and technology is needed that has sufficient sensitivity and specificity to enumerate and characterize these cells. The present system was developed to provide an immunophenotype, based on fluorescence waveforms as well as images of immunomagnetically-enriched cells. Blood volumes ranging from 7.5-30ml are immunomagnetically enriched for epithelial cells. The sample volume is reduced to 320ul and inserted into an analysis chamber. Upon introduction of the chamber in a magnetic field, the immunomagnetically tagged cells rise out of the sample and align between nickel lines (period 30µm, space 15µm) that are present on the viewing surface of the chamber.
PCT/US2003/013842 2002-05-03 2003-05-05 Device and method for analytical cell imaging WO2003093795A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CA002484730A CA2484730A1 (en) 2002-05-03 2003-05-05 Device and method for analytical cell imaging
JP2004501911A JP2005524833A (en) 2002-05-03 2003-05-05 Devices and methods for analytical cell imaging
EP03728685A EP1501917A4 (en) 2002-05-03 2003-05-05 Device and method for analytical cell imaging
AU2003234459A AU2003234459A1 (en) 2002-05-03 2003-05-05 Device and method for analytical cell imaging

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37786802P 2002-05-03 2002-05-03
US60/377,868 2002-05-03

Publications (2)

Publication Number Publication Date
WO2003093795A2 WO2003093795A2 (en) 2003-11-13
WO2003093795A3 true WO2003093795A3 (en) 2004-10-21

Family

ID=29401578

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/013842 WO2003093795A2 (en) 2002-05-03 2003-05-05 Device and method for analytical cell imaging

Country Status (5)

Country Link
EP (1) EP1501917A4 (en)
JP (1) JP2005524833A (en)
AU (1) AU2003234459A1 (en)
CA (1) CA2484730A1 (en)
WO (1) WO2003093795A2 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8137912B2 (en) 2006-06-14 2012-03-20 The General Hospital Corporation Methods for the diagnosis of fetal abnormalities
US8168389B2 (en) 2006-06-14 2012-05-01 The General Hospital Corporation Fetal cell analysis using sample splitting
US8195415B2 (en) 2008-09-20 2012-06-05 The Board Of Trustees Of The Leland Stanford Junior University Noninvasive diagnosis of fetal aneuploidy by sequencing
US8921102B2 (en) 2005-07-29 2014-12-30 Gpb Scientific, Llc Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US8986966B2 (en) 2002-09-27 2015-03-24 The General Hospital Corporation Microfluidic device for cell separation and uses thereof
US9174222B2 (en) 2005-04-05 2015-11-03 The General Hospital Corporation Devices and method for enrichment and alteration of cells and other particles

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4041458B2 (en) * 2003-12-12 2008-01-30 日立ソフトウエアエンジニアリング株式会社 Fluorescent bead detection method and fluorescent bead detection device
US7468796B2 (en) 2004-08-06 2008-12-23 Compucyte Corporation Multiple-color monochromatic light absorption and quantification of light absorption in a stained sample
CA2584993A1 (en) * 2004-10-22 2006-04-27 Bevan Leslie Reid Analytical method and apparatus
US9134237B2 (en) * 2005-09-20 2015-09-15 Janssen Diagnotics, LLC High sensitivity multiparameter method for rare event analysis in a biological sample
EP3211086B1 (en) 2005-09-20 2021-06-09 Menarini Silicon Biosystems S.p.A. Methods and composition to generate unique sequence dna probes, labeling of dna probes and the use of these probes
FI20051329A0 (en) 2005-12-27 2005-12-27 Wallac Oy Apparatus and method for optical measurement of samples
JP2009537021A (en) * 2006-05-12 2009-10-22 ベリデックス・リミテッド・ライアビリティ・カンパニー Laser irradiation system in fluorescence microscopy
US20080050739A1 (en) 2006-06-14 2008-02-28 Roland Stoughton Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats
US20080070792A1 (en) 2006-06-14 2008-03-20 Roland Stoughton Use of highly parallel snp genotyping for fetal diagnosis
WO2008012724A2 (en) * 2006-07-20 2008-01-31 Koninklijke Philips Electronics N.V. Optical tracking and position determination for detection methods and systems
US7782452B2 (en) * 2007-08-31 2010-08-24 Kla-Tencor Technologies Corp. Systems and method for simultaneously inspecting a specimen with two distinct channels
US8143600B2 (en) * 2008-02-18 2012-03-27 Visiongate, Inc. 3D imaging of live cells with ultraviolet radiation
JP5119114B2 (en) * 2008-09-30 2013-01-16 富士フイルム株式会社 Light source device and photographing device
JP4805418B1 (en) * 2010-03-31 2011-11-02 古河電気工業株式会社 Cell identification device and identification method
AU2012231737B2 (en) 2011-03-24 2015-07-23 Ningkasai Technology (Shanghai) Co, Ltd. Micro-devices for disease detection
CN107034132A (en) * 2011-05-05 2017-08-11 安派科生物医学科技有限公司 Tumour cell detector
MX2014000095A (en) * 2011-07-07 2014-05-28 Janssen Diagnostics Llc Method of analyzing cardiovascular disorders and uses thereof.
US9511152B2 (en) * 2012-04-05 2016-12-06 The Board Of Regents Of The University Of Texas System Multicolored pH-activatable fluorescence nanoplatform
CN104914078A (en) * 2015-04-16 2015-09-16 南京昊控软件技术有限公司 Large-range multi-point fluid concentration measuring system
CA3220119A1 (en) * 2016-03-07 2017-09-14 X-Zell Inc. Compositions and methods for identifying rare cells
FR3051556A1 (en) * 2016-05-18 2017-11-24 Biocytex USE OF FLUORESCENT MARKERS FOR THE DETECTION OF BIOLOGICAL TARGET IN A SAMPLE

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5034613A (en) * 1989-11-14 1991-07-23 Cornell Research Foundation, Inc. Two-photon laser microscopy
US5127730A (en) * 1990-08-10 1992-07-07 Regents Of The University Of Minnesota Multi-color laser scanning confocal imaging system
US5479252A (en) * 1993-06-17 1995-12-26 Ultrapointe Corporation Laser imaging system for inspection and analysis of sub-micron particles
US5691839A (en) * 1993-04-15 1997-11-25 Kowa Company Ltd. Laser scanning optical microscope
US5698397A (en) * 1995-06-07 1997-12-16 Sri International Up-converting reporters for biological and other assays using laser excitation techniques

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5034613A (en) * 1989-11-14 1991-07-23 Cornell Research Foundation, Inc. Two-photon laser microscopy
US5127730A (en) * 1990-08-10 1992-07-07 Regents Of The University Of Minnesota Multi-color laser scanning confocal imaging system
US5691839A (en) * 1993-04-15 1997-11-25 Kowa Company Ltd. Laser scanning optical microscope
US5479252A (en) * 1993-06-17 1995-12-26 Ultrapointe Corporation Laser imaging system for inspection and analysis of sub-micron particles
US5698397A (en) * 1995-06-07 1997-12-16 Sri International Up-converting reporters for biological and other assays using laser excitation techniques

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8986966B2 (en) 2002-09-27 2015-03-24 The General Hospital Corporation Microfluidic device for cell separation and uses thereof
US9174222B2 (en) 2005-04-05 2015-11-03 The General Hospital Corporation Devices and method for enrichment and alteration of cells and other particles
US8921102B2 (en) 2005-07-29 2014-12-30 Gpb Scientific, Llc Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US8372584B2 (en) 2006-06-14 2013-02-12 The General Hospital Corporation Rare cell analysis using sample splitting and DNA tags
US8137912B2 (en) 2006-06-14 2012-03-20 The General Hospital Corporation Methods for the diagnosis of fetal abnormalities
US9017942B2 (en) 2006-06-14 2015-04-28 The General Hospital Corporation Rare cell analysis using sample splitting and DNA tags
US8168389B2 (en) 2006-06-14 2012-05-01 The General Hospital Corporation Fetal cell analysis using sample splitting
US9273355B2 (en) 2006-06-14 2016-03-01 The General Hospital Corporation Rare cell analysis using sample splitting and DNA tags
US9347100B2 (en) 2006-06-14 2016-05-24 Gpb Scientific, Llc Rare cell analysis using sample splitting and DNA tags
US8296076B2 (en) 2008-09-20 2012-10-23 The Board Of Trustees Of The Leland Stanford Junior University Noninvasive diagnosis of fetal aneuoploidy by sequencing
US8682594B2 (en) 2008-09-20 2014-03-25 The Board Of Trustees Of The Leland Stanford Junior University Noninvasive diagnosis of fetal aneuploidy by sequencing
US8195415B2 (en) 2008-09-20 2012-06-05 The Board Of Trustees Of The Leland Stanford Junior University Noninvasive diagnosis of fetal aneuploidy by sequencing
US9353414B2 (en) 2008-09-20 2016-05-31 The Board Of Trustees Of The Leland Stanford Junior University Noninvasive diagnosis of fetal aneuploidy by sequencing
US9404157B2 (en) 2008-09-20 2016-08-02 The Board Of Trustees Of The Leland Stanford Junior University Noninvasive diagnosis of fetal aneuploidy by sequencing

Also Published As

Publication number Publication date
EP1501917A2 (en) 2005-02-02
AU2003234459A8 (en) 2003-11-17
AU2003234459A1 (en) 2003-11-17
EP1501917A4 (en) 2006-04-19
JP2005524833A (en) 2005-08-18
WO2003093795A2 (en) 2003-11-13
CA2484730A1 (en) 2003-11-13

Similar Documents

Publication Publication Date Title
WO2003093795A3 (en) Device and method for analytical cell imaging
WO2003019141A3 (en) Analysis of circulating tumor cells, fragments, and debris
US20110195413A1 (en) Integrated Method for Enriching and Detecting Rare Cells from Biological Body Fluid Sample
CA2395325A1 (en) Method of cancer screening primarily utilizing non-invasive cell collection and fluorescence detection techniques
Washtien et al. Assay of intracellular free and macromolecular-bound metabolites of 5-fluorodeoxyuridine and 5-fluorouracil
EP2305833A3 (en) Markers for detection of gastric cancer
AUPP915799A0 (en) Sample collection and testing system
Beitsch et al. Detection of carcinoma cells in the blood of breast cancer patients
Favrot et al. Histological, cytological and immunological analyses are complementary for the detection of neuroblastoma cells in bone marrow
CA2429526A1 (en) Compositions and methods for detecting pre-cancerous conditions in cell and tissue samples using 5, 10, 15, 20-tetrakis (carboxyphenyl) porphine
Bose et al. Quantitative evaluation and correlation of serum glycoconjugates: Protein bound hexoses, sialic acid and fucose in leukoplakia, oral sub mucous fibrosis and oral cancer
CN109457032A (en) Thyroid cancer molecule diagnosis kit
Jin‐Ming et al. Flow cytometric analysis DNA content in esophageal carcinoma. Correlation with histologic and clinical features
Pachmann et al. Comparing sequential steps for detection of circulating tumor cells: more specific or just less sensitive?
CN101354379A (en) Reagent for detecting multiple myeloma characteristic protein by mass spectrum
Cereto et al. Validation of automated blood cell counters for the diagnosis of spontaneous bacterial peritonitis
Sekizawa et al. Development of noninvasive fetal DNA diagnosis from nucleated erythrocytes circulating in maternal blood
Kumar et al. DNA flow cytometry and bladder irrigation cytology in detection of bladder carcinoma
Yang et al. Recent advances in protein profiling of tissues and tissue fluids
Hayes et al. Regional cell proliferation in microdissected human prostate specimens after heavy water labeling in vivo: correlation with prostate epithelial cells isolated from seminal fluid
Molek et al. Plasmacytoid urothelial carcinoma—diagnostic challenge in cytology
CN1920570B (en) Application of thioredoxin protein 2
WO2005034736A3 (en) Generation of biochemical images and methods of use
RU2006112203A (en) EXPRESS TEST FOR DIAGNOSTIC OF ALZHEIMER&#39;S DISEASE
WO2006051551A3 (en) Device and method for analysis of a metabolic malady

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2004501911

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2003728685

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2484730

Country of ref document: CA

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWP Wipo information: published in national office

Ref document number: 2003728685

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2003728685

Country of ref document: EP